pre-seed
Stage
1
Investors
About
Pannex Therapeutics develops therapies that block Pannexin 1 channels to treat neuroinflammatory and immune-driven conditions in neurology and oncology by targeting pathological ATP release.
Explore Pannex Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.